Cardiac transplantation: any role left?
Cardiac transplantation: any role left?
复制标题
DOI：
10.1016/j.hfc.2007.04.004
复制
发表时间：
2007-07-01
影响因子：
3.4
通讯作者：
Deng, Mario C
中科院分区：
文献类型：
--
作者：
Cadeiras, Martin;von Bayern, Manuel Prinz;Deng, Mario C
作者分析了心脏移植在当今复杂技术时代是否仍然发挥作用的问题。为了实现这一目标，作者首先讨论了目前可用于终末期心力衰竭患者的不同治疗方式的已知受益，包括药物管理、电生理治疗、高风险手术策略、机械循环支持装置植入治疗和心脏移植。然后，作者评估了该领域的当前发展和未来前景，这些发展和前景可能会影响心脏移植作为终末期心力衰竭治疗方式的可能性。
The authors analyze the question of whether heart transplantation still has a role in the current era of complex technologies. To achieve this objective, the authors first discuss the known benefits of different therapeutic modalities currently available for patients who have end-stage heart failure, including pharmacologic management, electrophysiologic therapies, high-risk surgical strategies, implantation of mechanical circulatory support device therapy, and heart transplantation. The authors then evaluate the current developments and future perspectives in the field that may influence the likelihood of heart transplantation to remain the therapeutic modality of choice for end-stage heart failure.